HIV-1 vaccine clinical trials: the Brazi
โ
Jonatan Ersching; Aguinaldo R. Pinto
๐
Article
๐
2009
๐
John Wiley and Sons
๐
English
โ 161 KB
## Abstract Although the development of an effective HIVโ1 vaccine has proved very challenging for more than two decades, it remains the best hope to control the HIV pandemic. Since Brazil has particular epidemiological features, as well as adequate policies and infrastructure, the country has been